The largest database of trusted experimental protocols

5 protocols using h2 kb siinfekl dextramer

1

Quantifying CD8+ T Cell Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experimental groups were infected or not with 103 LM-OVA for 7 days. At 7 days post-infection, spleens were harvested, processed to a single-cell suspension, and stained individually with anti-mouse CD8 antibody (BD Biosciences, 563898) and H2-Kb-SIINFEKL Dextramer (Immudex, Copenhagen, Denmark, JD2163) according to manufacturer’s instruction. Samples were analyzed by FACS using BD FACSCelestaTM (BD, Mountain View, CA, United States). Each sample was analyzed independently by using the gating strategy shown in Supplementary Figure S1. Finally, the frequency of CD8+ H2-Kb–SIINFEKL+ population of each sample was evaluated separately using FlowJo v10 workspace.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimouse antibodies for CD45 (30-F11), CD4 (GK1.5 or RM4-5), CD8a (53–6.7), CD44 (IM7), CD127 (SB/199), CD62-L (MEL-14), KLRG1 (2F1), IFNγ (XMG1.2), TNFα (MP6-XT22), IL-2 (JES6-5H4), CD107a (1D4B), FoxP3 (FJK-16s) were obtained from eBioscience (Paris, France) or BD Biosciences (San Jose, CA). H2Kb-SIINFEKL Dextramer, a multimer of H2Kb loaded with OVA257-264 antigen was purchased at Immudex (Copenhagen, Denmark). Staining was performed as described by manufacturer’s instruction. The Fixable Viability Dye (FVD eF780, eBioscience) was used for tumor-infiltrated study in order to exclude dead cells for flow cytometry analysis. Flow cytometry acquisition was done using a BD Biosciences FACSCanto II and analysis carried out with FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
3

Evaluating Combination Immunotherapy in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were implanted with MC38OVA-GFP cells and injected intraperitoneally with SAR439459 or isotype control at 25 mpk, mouse PD-1 antibody, or isotype (MOPC-21) at 5 mpk or their combination; mice were given a total of 6 treatment doses in 3 weeks (2/week). Tumors, spleen, and tumor-draining lymph nodes were harvested, and used for preparing single-cell suspensions. Tumors were digested by tumor digestion kit as instructed (Miltenyi Biotec, 130–096-730), whereas lymph nodes and splenocytes were passed through cell strainers (Falcon, 352350). Cells were stained with the H2Kb-SIINFEKL dextramer (Immudex, JD2163-PE and JD2163-APC) as instructed by the manufacturer, followed by Fc blocking (BioLegend, 101320). An antibody cocktail was prepared by mixing anti- CD45-BUV395 (BD Bioscience, 564279), CD8-BV510 (Biolegend, 100752), CD4-BV421, (Biolegend, 100438), CD44-PerCP/Cy5.5 (Biolegend, 103032), CD62L-AF700 (Biolegend, 104426), and CD69-BV711 (Biolegend, 104537) in Brilliant Stain Buffer (BD Bioscience, 563794), and cell suspensions were stained for 30 minutes at 4°C followed by staining with dead cell exclusion dye (Zombie NIR; BioLegend, 423106) and fixed with 1% formaldehyde (Electron Microscopy Systems, 15710) diluted in PBS (GIBCO, 10010–023). Samples were acquired on LSRFortessa (BD Biosciences) and analyzed using FlowJo software.
+ Open protocol
+ Expand
4

Isolation and In Vitro Activation of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were excised and subjected to manual homogenization. T cells were isolated by density gradient separation with Lympholyte-m (Cedarlane). For in vitro function, isolated T cells were stimulated with plate-bound αCD3 (1μg/mL; eBioscience) or OVA257 peptide pulsed, CD45-mismatched splenocytes. H-2Kb/SIINFEKL dextramer (Immudex) was used to identify OVA257 specific CD8. Antibodies and reagents used for staining are listed in Table S1.
+ Open protocol
+ Expand
5

Isolation and Functional Assay of Tumor-Infiltrating T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were excised and subjected to manual homogenization. T cells were isolated by density gradient separation with Lympholyte-m (Cedarlane). For in vitro function, isolated T cells were (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
Pre-existing intratumoral CD8 T cells substantially contribute to control tumors following therapeutic anti-CD40 and polyI:C based vaccination 8 stimulated with plate-bound αCD3 (1µg/mL; eBioscience) or OVA257 peptide pulsed, CD45mismatched splenocytes. H-2K b /SIINFEKL dextramer (Immudex) was used to identify OVA257 specific CD8. Antibodies and reagents used for staining are listed in table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!